ข่าวประชาสัมพันธ์ Lung Cancer+vandetanib

Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology

Data from the Phase III ZODIAC(1) study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, demonstrating that the addition of vandetanib to docetaxel resulted in a statistically significant improvement in progression-free survival (PFS), the length of time a patient lives without their cancer growing (hazard

01 มิถุนายน 2552 08:51 น.

Fourth Phase III Study of Vandetanib (ZACTIMA(TM), ZD6474) in Patients With Advanced Lung Cancer

A Phase III international, parallel group, randomised, double-blind study of vandetanib in combination with pemetrexed for advanced non-small cell lung cancer (NSCLC) after failure of first line anti... ก.พ. 50

Nearly 80% of Doctors Worldwide Mistakenly Believe Nicotine Causes Lung Cancer, Thwarting Efforts to Help One Billion Smokers Quit

Survey of more than 15,000 physicians in 11 countries uncovers need for further educationThe Foundation for a Smoke-Free World invites researchers to propose new analysis... ก.ค. 66

แอสตร้าเซนเนก้า ประเทศไทย ประกาศความร่วมมือ โรงพยาบาลพญาไท 2 นำนวัตกรรม AI เพิ่มประสิทธิภาพการตรวจหามะเร็งปอดระยะเริ่มต้น — บริษัท แอสตร้าเซนเนก้า (ประเทศ... มี.ค. 66

เสวนาวันมะเร็งปอดโลก: ดูแลปอด ดูแลใจ เพื่อผู้ป่วยมะเร็งปอด — วันมะเร็งปอดโลกซึ่งตรงกับวันที่ตรงกับวันที่ 1 สิงหาคมของทุกปี จัดขึ้นเพื่อรณรงค์ให้คนทั่วโลกห... ส.ค. 64

TLCG organizes the "Innovations for Thai Lung Cancer Patients 2020" with the launch "LungAndMe" — Thai Lung Cancer Group (TLCG) organizes the "Innovations... ธ.ค. 63

Innovations for Thai Lung Cancer Patients 2020 launch "LungAndMe" — Innovations for Thai Lung Cancer Patients 2020: evolving treatments for lung cancerBri... ธ.ค. 63

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Not intended for UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial... ก.พ. 61

โรงพยาบาลวัฒโนสถเชิญชวนตรวจมะเร็งปอดเนื่องในวันงดสูบบุหรี่โลก (Package Lung Cancer Early Detection ) — โรงพยาบาลวัฒโนสถ ขอเชิญชวนผู้ที่สนใจตรวจสุขภาพ "ป้อ... พ.ค. 60

Registration & Abstract Submission Open for IASLC's 2016 World Conference on Lung Cancer in Vienna

Largest Worldwide Lung Cancer Research Organization Invites Global Collaborators to Attend Registration and abstract submission is now open for the International Association for the Study of Lung Cancer... มี.ค. 59

Global Strategic Partners Merck and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

Not intended for UK-based media First of several registration trials expected to start in 2015 for the alliance between Merck and Pfizer Initiation and first... เม.ย. 58

Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer

Not intended for UK-based media Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1... ก.ย. 57

Lung Cancer Stage Four 10 Years Cancer-Free Through Non-toxic Alternative Cancer Treatment

Recurrent lung cancer responds to Integrative Immunotherapy Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis.... ก.พ. 57

Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology

Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with... ธ.ค. 56

ALIMTA(R) Label Update Approved by European Commission to Reflect Significant Overall Survival Benefits for Specific Lung Cancer Patients

Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has approved an update to the label for ALIMTA(R) (pemetrexed for injection), adding... ต.ค. 55

Cytocell Ltd Introduces New ROS1 Genetic Test for Non-Small-Cell Lung Cancer

Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung cancer (NSCLC). These... ต.ค. 55

Avastin Shows Longest Overall Survival for Patients With Adenocarcinoma, the Most Common Type of Advanced Lung Cancer

This update outlines data from a preplanned analysis of the pivotal E4599 study in patients with non-small cell lung cancer (NSCLC), published in the Journal of Thoracic Oncology. The... ส.ค. 53

Large 'Real-World' Study Shows Avastin-based Therapy Extends Survival Beyond Fourteen Months in Patients With Advanced Lung Cancer

- For non-US, non-UK Media Only - Avastin Benefits Demonstrated in Combination With a Wide Range of Chemotherapies and in a Broad Patient Population New data show that... ก.ค. 53

Tarceva Helps Patients With Genetically Distinct Form of Lung Cancer Live Longer

- For non-US, non-UK Media Only - Phase II Study Points to Importance of EGFR Biomarker to Identify Patients who can Gain Exceptional Survival BenefitsNew data show that first-line treatment with Tarceva(R)(erlotinib)... มิ.ย. 53

Tarceva Receives Positive Opinion in Europe for Maintenance Treatment of Advanced Lung Cancer

- Approval Would Allow Patients to Benefit From Earlier Use of Well-Tolerated Oral Treatment Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Committee for Medicinal Products for Human... มี.ค. 53

วันมะเร็งปอด Lung Cancer Day

โรงพยาบาลไทยนครินทร์ จัดกิจกรรมรณรงค์เนื่องในวันมะเร็งปอด หรือ Lung Cancer Day ภายในงานได้มีการจัดบอร์ดนิทรรศการให้ความรู้การดูแลตนเองให้ห่างไกลจากโรคมะเร็งปอดและตั้งจุดบริการสืบค้นโอกาสเสี่ยงโดยใช้โปรแกรม Family Tree ผ่านระบบคอมพิวเตอร์ (จากภาพ) นพ.เจริญ มีนสุข... พ.ย. 52

Maintenance Treatment With Avastin and Tarceva in Combination Helps Lung Cancer Patients Live Longer Without Their Disease Worsening

- Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study showed patients with advanced non... มิ.ย. 52